img

Global Medical Anti-infective Agent Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Medical Anti-infective Agent Market Insights, Forecast to 2034

Medical anti-infective agents are a class of medications used to treat infections caused by various microorganisms, including bacteria, viruses, fungi, and parasites. These agents play a crucial role in modern medicine by helping to control and treat infectious diseases, preventing their spread, and improving patient outcomes.
Global Medical Anti-infective Agent market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Medical Anti-infective Agent industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global market for medical anti-infective agents has been steadily growing over the years due to the increasing incidence of infectious diseases, rising antimicrobial resistance, and the continuous development of new anti-infective therapies. The demand for effective treatments against various infections, including bacterial, viral, fungal, and parasitic infections, has driven the growth of this market. North America and Europe have been dominant regions in the medical anti-infective agent market, owing to well-established healthcare infrastructures, a high prevalence of infectious diseases, and robust research and development activities in these regions. The Asia Pacific region has shown significant growth potential in the market due to the increasing incidence of infectious diseases, improving healthcare facilities, and growing awareness of antimicrobial resistance.
Report Covers
This report presents an overview of global Medical Anti-infective Agent market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Medical Anti-infective Agent market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novartis
Pfizer
Sanofi
Abbott Laboratories
Johnson & Johnson
Alembic Pharmaceuticals
Bayer
Mankind Pharma
Gilead Sciences
AstraZeneca
Boehringer Ingelheim
Astellas Pharma
GSK
Segment by Type
Anti-Viral
Anti-Fungal
Anti-Bacterial
Others

Segment by Application


Hospital
Clinic
Home

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Medical Anti-infective Agent plant distribution, commercial date of Medical Anti-infective Agent, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Medical Anti-infective Agent introduction, etc. Medical Anti-infective Agent Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Medical Anti-infective Agent
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Medical Anti-infective Agent Product Introduction
1.2 Market by Type
1.2.1 Global Medical Anti-infective Agent Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Anti-Viral
1.2.3 Anti-Fungal
1.2.4 Anti-Bacterial
1.2.5 Others
1.3 Market by Application
1.3.1 Global Medical Anti-infective Agent Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Medical Anti-infective Agent Sales Estimates and Forecasts 2018-2029
2.2 Global Medical Anti-infective Agent Revenue by Region
2.2.1 Global Medical Anti-infective Agent Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Medical Anti-infective Agent Revenue by Region (2018-2024)
2.2.3 Global Medical Anti-infective Agent Revenue by Region (2024-2029)
2.2.4 Global Medical Anti-infective Agent Revenue Market Share by Region (2018-2029)
2.3 Global Medical Anti-infective Agent Sales Estimates and Forecasts 2018-2029
2.4 Global Medical Anti-infective Agent Sales by Region
2.4.1 Global Medical Anti-infective Agent Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Medical Anti-infective Agent Sales by Region (2018-2024)
2.4.3 Global Medical Anti-infective Agent Sales by Region (2024-2029)
2.4.4 Global Medical Anti-infective Agent Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Medical Anti-infective Agent Sales by Manufacturers
3.1.1 Global Medical Anti-infective Agent Sales by Manufacturers (2018-2024)
3.1.2 Global Medical Anti-infective Agent Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Medical Anti-infective Agent in 2022
3.2 Global Medical Anti-infective Agent Revenue by Manufacturers
3.2.1 Global Medical Anti-infective Agent Revenue by Manufacturers (2018-2024)
3.2.2 Global Medical Anti-infective Agent Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Medical Anti-infective Agent Revenue in 2022
3.3 Global Key Players of Medical Anti-infective Agent, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Medical Anti-infective Agent Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Medical Anti-infective Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Medical Anti-infective Agent, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Medical Anti-infective Agent, Product Offered and Application
3.8 Global Key Manufacturers of Medical Anti-infective Agent, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Medical Anti-infective Agent Sales by Type
4.1.1 Global Medical Anti-infective Agent Historical Sales by Type (2018-2024)
4.1.2 Global Medical Anti-infective Agent Forecasted Sales by Type (2024-2029)
4.1.3 Global Medical Anti-infective Agent Sales Market Share by Type (2018-2029)
4.2 Global Medical Anti-infective Agent Revenue by Type
4.2.1 Global Medical Anti-infective Agent Historical Revenue by Type (2018-2024)
4.2.2 Global Medical Anti-infective Agent Forecasted Revenue by Type (2024-2029)
4.2.3 Global Medical Anti-infective Agent Revenue Market Share by Type (2018-2029)
4.3 Global Medical Anti-infective Agent Price by Type
4.3.1 Global Medical Anti-infective Agent Price by Type (2018-2024)
4.3.2 Global Medical Anti-infective Agent Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Medical Anti-infective Agent Sales by Application
5.1.1 Global Medical Anti-infective Agent Historical Sales by Application (2018-2024)
5.1.2 Global Medical Anti-infective Agent Forecasted Sales by Application (2024-2029)
5.1.3 Global Medical Anti-infective Agent Sales Market Share by Application (2018-2029)
5.2 Global Medical Anti-infective Agent Revenue by Application
5.2.1 Global Medical Anti-infective Agent Historical Revenue by Application (2018-2024)
5.2.2 Global Medical Anti-infective Agent Forecasted Revenue by Application (2024-2029)
5.2.3 Global Medical Anti-infective Agent Revenue Market Share by Application (2018-2029)
5.3 Global Medical Anti-infective Agent Price by Application
5.3.1 Global Medical Anti-infective Agent Price by Application (2018-2024)
5.3.2 Global Medical Anti-infective Agent Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Medical Anti-infective Agent Market Size by Type
6.1.1 US & Canada Medical Anti-infective Agent Sales by Type (2018-2029)
6.1.2 US & Canada Medical Anti-infective Agent Revenue by Type (2018-2029)
6.2 US & Canada Medical Anti-infective Agent Market Size by Application
6.2.1 US & Canada Medical Anti-infective Agent Sales by Application (2018-2029)
6.2.2 US & Canada Medical Anti-infective Agent Revenue by Application (2018-2029)
6.3 US & Canada Medical Anti-infective Agent Market Size by Country
6.3.1 US & Canada Medical Anti-infective Agent Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Medical Anti-infective Agent Sales by Country (2018-2029)
6.3.3 US & Canada Medical Anti-infective Agent Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Medical Anti-infective Agent Market Size by Type
7.1.1 Europe Medical Anti-infective Agent Sales by Type (2018-2029)
7.1.2 Europe Medical Anti-infective Agent Revenue by Type (2018-2029)
7.2 Europe Medical Anti-infective Agent Market Size by Application
7.2.1 Europe Medical Anti-infective Agent Sales by Application (2018-2029)
7.2.2 Europe Medical Anti-infective Agent Revenue by Application (2018-2029)
7.3 Europe Medical Anti-infective Agent Market Size by Country
7.3.1 Europe Medical Anti-infective Agent Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Medical Anti-infective Agent Sales by Country (2018-2029)
7.3.3 Europe Medical Anti-infective Agent Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Medical Anti-infective Agent Market Size
8.1.1 China Medical Anti-infective Agent Sales (2018-2029)
8.1.2 China Medical Anti-infective Agent Revenue (2018-2029)
8.2 China Medical Anti-infective Agent Market Size by Application
8.2.1 China Medical Anti-infective Agent Sales by Application (2018-2029)
8.2.2 China Medical Anti-infective Agent Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Medical Anti-infective Agent Market Size by Type
9.1.1 Asia Medical Anti-infective Agent Sales by Type (2018-2029)
9.1.2 Asia Medical Anti-infective Agent Revenue by Type (2018-2029)
9.2 Asia Medical Anti-infective Agent Market Size by Application
9.2.1 Asia Medical Anti-infective Agent Sales by Application (2018-2029)
9.2.2 Asia Medical Anti-infective Agent Revenue by Application (2018-2029)
9.3 Asia Medical Anti-infective Agent Sales by Region
9.3.1 Asia Medical Anti-infective Agent Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Medical Anti-infective Agent Revenue by Region (2018-2029)
9.3.3 Asia Medical Anti-infective Agent Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Medical Anti-infective Agent Market Size by Type
10.1.1 Middle East, Africa and Latin America Medical Anti-infective Agent Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Medical Anti-infective Agent Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Medical Anti-infective Agent Market Size by Application
10.2.1 Middle East, Africa and Latin America Medical Anti-infective Agent Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Medical Anti-infective Agent Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Medical Anti-infective Agent Sales by Country
10.3.1 Middle East, Africa and Latin America Medical Anti-infective Agent Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Medical Anti-infective Agent Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Medical Anti-infective Agent Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Medical Anti-infective Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Novartis Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Medical Anti-infective Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Pfizer Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Medical Anti-infective Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Sanofi Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Information
11.4.2 Abbott Laboratories Overview
11.4.3 Abbott Laboratories Medical Anti-infective Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Abbott Laboratories Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Abbott Laboratories Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Overview
11.5.3 Johnson & Johnson Medical Anti-infective Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Johnson & Johnson Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Johnson & Johnson Recent Developments
11.6 Alembic Pharmaceuticals
11.6.1 Alembic Pharmaceuticals Company Information
11.6.2 Alembic Pharmaceuticals Overview
11.6.3 Alembic Pharmaceuticals Medical Anti-infective Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Alembic Pharmaceuticals Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Alembic Pharmaceuticals Recent Developments
11.7 Bayer
11.7.1 Bayer Company Information
11.7.2 Bayer Overview
11.7.3 Bayer Medical Anti-infective Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Bayer Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bayer Recent Developments
11.8 Mankind Pharma
11.8.1 Mankind Pharma Company Information
11.8.2 Mankind Pharma Overview
11.8.3 Mankind Pharma Medical Anti-infective Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Mankind Pharma Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mankind Pharma Recent Developments
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Information
11.9.2 Gilead Sciences Overview
11.9.3 Gilead Sciences Medical Anti-infective Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Gilead Sciences Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Gilead Sciences Recent Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Company Information
11.10.2 AstraZeneca Overview
11.10.3 AstraZeneca Medical Anti-infective Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 AstraZeneca Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 AstraZeneca Recent Developments
11.11 Boehringer Ingelheim
11.11.1 Boehringer Ingelheim Company Information
11.11.2 Boehringer Ingelheim Overview
11.11.3 Boehringer Ingelheim Medical Anti-infective Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Boehringer Ingelheim Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Boehringer Ingelheim Recent Developments
11.12 Astellas Pharma
11.12.1 Astellas Pharma Company Information
11.12.2 Astellas Pharma Overview
11.12.3 Astellas Pharma Medical Anti-infective Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Astellas Pharma Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Astellas Pharma Recent Developments
11.13 GSK
11.13.1 GSK Company Information
11.13.2 GSK Overview
11.13.3 GSK Medical Anti-infective Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 GSK Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 GSK Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Medical Anti-infective Agent Industry Chain Analysis
12.2 Medical Anti-infective Agent Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Medical Anti-infective Agent Production Mode & Process
12.4 Medical Anti-infective Agent Sales and Marketing
12.4.1 Medical Anti-infective Agent Sales Channels
12.4.2 Medical Anti-infective Agent Distributors
12.5 Medical Anti-infective Agent Customers
13 Market Dynamics
13.1 Medical Anti-infective Agent Industry Trends
13.2 Medical Anti-infective Agent Market Drivers
13.3 Medical Anti-infective Agent Market Challenges
13.4 Medical Anti-infective Agent Market Restraints
14 Key Findings in The Global Medical Anti-infective Agent Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Medical Anti-infective Agent Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Anti-Viral
Table 3. Major Manufacturers of Anti-Fungal
Table 4. Major Manufacturers of Anti-Bacterial
Table 5. Major Manufacturers of Others
Table 6. Global Medical Anti-infective Agent Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Medical Anti-infective Agent Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Medical Anti-infective Agent Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Medical Anti-infective Agent Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Medical Anti-infective Agent Revenue Market Share by Region (2018-2024)
Table 11. Global Medical Anti-infective Agent Revenue Market Share by Region (2024-2029)
Table 12. Global Medical Anti-infective Agent Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Medical Anti-infective Agent Sales by Region (2018-2024) & (K Units)
Table 14. Global Medical Anti-infective Agent Sales by Region (2024-2029) & (K Units)
Table 15. Global Medical Anti-infective Agent Sales Market Share by Region (2018-2024)
Table 16. Global Medical Anti-infective Agent Sales Market Share by Region (2024-2029)
Table 17. Global Medical Anti-infective Agent Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Medical Anti-infective Agent Sales Share by Manufacturers (2018-2024)
Table 19. Global Medical Anti-infective Agent Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Medical Anti-infective Agent Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Medical Anti-infective Agent, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Medical Anti-infective Agent Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Medical Anti-infective Agent Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Medical Anti-infective Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Anti-infective Agent as of 2022)
Table 25. Global Key Manufacturers of Medical Anti-infective Agent, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Medical Anti-infective Agent, Product Offered and Application
Table 27. Global Key Manufacturers of Medical Anti-infective Agent, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Medical Anti-infective Agent Sales by Type (2018-2024) & (K Units)
Table 30. Global Medical Anti-infective Agent Sales by Type (2024-2029) & (K Units)
Table 31. Global Medical Anti-infective Agent Sales Share by Type (2018-2024)
Table 32. Global Medical Anti-infective Agent Sales Share by Type (2024-2029)
Table 33. Global Medical Anti-infective Agent Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Medical Anti-infective Agent Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Medical Anti-infective Agent Revenue Share by Type (2018-2024)
Table 36. Global Medical Anti-infective Agent Revenue Share by Type (2024-2029)
Table 37. Medical Anti-infective Agent Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Medical Anti-infective Agent Price Forecast by Type (2024-2029) & (US$/Unit)
Table 39. Global Medical Anti-infective Agent Sales by Application (2018-2024) & (K Units)
Table 40. Global Medical Anti-infective Agent Sales by Application (2024-2029) & (K Units)
Table 41. Global Medical Anti-infective Agent Sales Share by Application (2018-2024)
Table 42. Global Medical Anti-infective Agent Sales Share by Application (2024-2029)
Table 43. Global Medical Anti-infective Agent Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Medical Anti-infective Agent Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Medical Anti-infective Agent Revenue Share by Application (2018-2024)
Table 46. Global Medical Anti-infective Agent Revenue Share by Application (2024-2029)
Table 47. Medical Anti-infective Agent Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Medical Anti-infective Agent Price Forecast by Application (2024-2029) & (US$/Unit)
Table 49. US & Canada Medical Anti-infective Agent Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Medical Anti-infective Agent Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Medical Anti-infective Agent Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Medical Anti-infective Agent Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Medical Anti-infective Agent Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Medical Anti-infective Agent Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Medical Anti-infective Agent Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Medical Anti-infective Agent Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Medical Anti-infective Agent Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Medical Anti-infective Agent Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Medical Anti-infective Agent Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Medical Anti-infective Agent Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Medical Anti-infective Agent Sales by Country (2024-2029) & (K Units)
Table 62. Europe Medical Anti-infective Agent Sales by Type (2018-2024) & (K Units)
Table 63. Europe Medical Anti-infective Agent Sales by Type (2024-2029) & (K Units)
Table 64. Europe Medical Anti-infective Agent Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Medical Anti-infective Agent Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Medical Anti-infective Agent Sales by Application (2018-2024) & (K Units)
Table 67. Europe Medical Anti-infective Agent Sales by Application (2024-2029) & (K Units)
Table 68. Europe Medical Anti-infective Agent Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Medical Anti-infective Agent Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Medical Anti-infective Agent Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Medical Anti-infective Agent Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Medical Anti-infective Agent Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Medical Anti-infective Agent Sales by Country (2018-2024) & (K Units)
Table 74. Europe Medical Anti-infective Agent Sales by Country (2024-2029) & (K Units)
Table 75. China Medical Anti-infective Agent Sales by Type (2018-2024) & (K Units)
Table 76. China Medical Anti-infective Agent Sales by Type (2024-2029) & (K Units)
Table 77. China Medical Anti-infective Agent Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Medical Anti-infective Agent Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Medical Anti-infective Agent Sales by Application (2018-2024) & (K Units)
Table 80. China Medical Anti-infective Agent Sales by Application (2024-2029) & (K Units)
Table 81. China Medical Anti-infective Agent Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Medical Anti-infective Agent Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Medical Anti-infective Agent Sales by Type (2018-2024) & (K Units)
Table 84. Asia Medical Anti-infective Agent Sales by Type (2024-2029) & (K Units)
Table 85. Asia Medical Anti-infective Agent Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Medical Anti-infective Agent Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Medical Anti-infective Agent Sales by Application (2018-2024) & (K Units)
Table 88. Asia Medical Anti-infective Agent Sales by Application (2024-2029) & (K Units)
Table 89. Asia Medical Anti-infective Agent Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Medical Anti-infective Agent Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Medical Anti-infective Agent Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Medical Anti-infective Agent Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Medical Anti-infective Agent Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Medical Anti-infective Agent Sales by Region (2018-2024) & (K Units)
Table 95. Asia Medical Anti-infective Agent Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Medical Anti-infective Agent Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Medical Anti-infective Agent Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Medical Anti-infective Agent Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Medical Anti-infective Agent Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Medical Anti-infective Agent Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Medical Anti-infective Agent Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Medical Anti-infective Agent Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Medical Anti-infective Agent Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Medical Anti-infective Agent Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Medical Anti-infective Agent Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Medical Anti-infective Agent Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Medical Anti-infective Agent Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Medical Anti-infective Agent Sales by Country (2024-2029) & (K Units)
Table 109. Novartis Company Information
Table 110. Novartis Description and Major Businesses
Table 111. Novartis Medical Anti-infective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Novartis Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Novartis Recent Developments
Table 114. Pfizer Company Information
Table 115. Pfizer Description and Major Businesses
Table 116. Pfizer Medical Anti-infective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Pfizer Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Pfizer Recent Developments
Table 119. Sanofi Company Information
Table 120. Sanofi Description and Major Businesses
Table 121. Sanofi Medical Anti-infective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Sanofi Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Sanofi Recent Developments
Table 124. Abbott Laboratories Company Information
Table 125. Abbott Laboratories Description and Major Businesses
Table 126. Abbott Laboratories Medical Anti-infective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Abbott Laboratories Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Abbott Laboratories Recent Developments
Table 129. Johnson & Johnson Company Information
Table 130. Johnson & Johnson Description and Major Businesses
Table 131. Johnson & Johnson Medical Anti-infective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Johnson & Johnson Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Johnson & Johnson Recent Developments
Table 134. Alembic Pharmaceuticals Company Information
Table 135. Alembic Pharmaceuticals Description and Major Businesses
Table 136. Alembic Pharmaceuticals Medical Anti-infective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Alembic Pharmaceuticals Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Alembic Pharmaceuticals Recent Developments
Table 139. Bayer Company Information
Table 140. Bayer Description and Major Businesses
Table 141. Bayer Medical Anti-infective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Bayer Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Bayer Recent Developments
Table 144. Mankind Pharma Company Information
Table 145. Mankind Pharma Description and Major Businesses
Table 146. Mankind Pharma Medical Anti-infective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Mankind Pharma Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Mankind Pharma Recent Developments
Table 149. Gilead Sciences Company Information
Table 150. Gilead Sciences Description and Major Businesses
Table 151. Gilead Sciences Medical Anti-infective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Gilead Sciences Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Gilead Sciences Recent Developments
Table 154. AstraZeneca Company Information
Table 155. AstraZeneca Description and Major Businesses
Table 156. AstraZeneca Medical Anti-infective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. AstraZeneca Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. AstraZeneca Recent Developments
Table 159. Boehringer Ingelheim Company Information
Table 160. Boehringer Ingelheim Description and Major Businesses
Table 161. Boehringer Ingelheim Medical Anti-infective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Boehringer Ingelheim Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Boehringer Ingelheim Recent Developments
Table 164. Astellas Pharma Company Information
Table 165. Astellas Pharma Description and Major Businesses
Table 166. Astellas Pharma Medical Anti-infective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Astellas Pharma Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Astellas Pharma Recent Developments
Table 169. GSK Company Information
Table 170. GSK Description and Major Businesses
Table 171. GSK Medical Anti-infective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. GSK Medical Anti-infective Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. GSK Recent Developments
Table 174. Key Raw Materials Lists
Table 175. Raw Materials Key Suppliers Lists
Table 176. Medical Anti-infective Agent Distributors List
Table 177. Medical Anti-infective Agent Customers List
Table 178. Medical Anti-infective Agent Market Trends
Table 179. Medical Anti-infective Agent Market Drivers
Table 180. Medical Anti-infective Agent Market Challenges
Table 181. Medical Anti-infective Agent Market Restraints
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Medical Anti-infective Agent Product Picture
Figure 2. Global Medical Anti-infective Agent Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Medical Anti-infective Agent Market Share by Type in 2022 & 2029
Figure 4. Anti-Viral Product Picture
Figure 5. Anti-Fungal Product Picture
Figure 6. Anti-Bacterial Product Picture
Figure 7. Others Product Picture
Figure 8. Global Medical Anti-infective Agent Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Medical Anti-infective Agent Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Home
Figure 13. Medical Anti-infective Agent Report Years Considered
Figure 14. Global Medical Anti-infective Agent Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Medical Anti-infective Agent Revenue 2018-2029 (US$ Million)
Figure 16. Global Medical Anti-infective Agent Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Medical Anti-infective Agent Revenue Market Share by Region (2018-2029)
Figure 18. Global Medical Anti-infective Agent Sales 2018-2029 ((K Units)
Figure 19. Global Medical Anti-infective Agent Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Medical Anti-infective Agent Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Medical Anti-infective Agent Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Medical Anti-infective Agent Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Medical Anti-infective Agent Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Medical Anti-infective Agent Sales YoY (2018-2029) & (K Units)
Figure 25. China Medical Anti-infective Agent Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Medical Anti-infective Agent Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Medical Anti-infective Agent Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Medical Anti-infective Agent Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Medical Anti-infective Agent Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Medical Anti-infective Agent Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Medical Anti-infective Agent in the World: Market Share by Medical Anti-infective Agent Revenue in 2022
Figure 32. Global Medical Anti-infective Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Medical Anti-infective Agent Sales Market Share by Type (2018-2029)
Figure 34. Global Medical Anti-infective Agent Revenue Market Share by Type (2018-2029)
Figure 35. Global Medical Anti-infective Agent Sales Market Share by Application (2018-2029)
Figure 36. Global Medical Anti-infective Agent Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Medical Anti-infective Agent Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Medical Anti-infective Agent Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Medical Anti-infective Agent Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Medical Anti-infective Agent Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Medical Anti-infective Agent Revenue Share by Country (2018-2029)
Figure 42. US & Canada Medical Anti-infective Agent Sales Share by Country (2018-2029)
Figure 43. U.S. Medical Anti-infective Agent Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Medical Anti-infective Agent Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Medical Anti-infective Agent Sales Market Share by Type (2018-2029)
Figure 46. Europe Medical Anti-infective Agent Revenue Market Share by Type (2018-2029)
Figure 47. Europe Medical Anti-infective Agent Sales Market Share by Application (2018-2029)
Figure 48. Europe Medical Anti-infective Agent Revenue Market Share by Application (2018-2029)
Figure 49. Europe Medical Anti-infective Agent Revenue Share by Country (2018-2029)
Figure 50. Europe Medical Anti-infective Agent Sales Share by Country (2018-2029)
Figure 51. Germany Medical Anti-infective Agent Revenue (2018-2029) & (US$ Million)
Figure 52. France Medical Anti-infective Agent Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Medical Anti-infective Agent Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Medical Anti-infective Agent Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Medical Anti-infective Agent Revenue (2018-2029) & (US$ Million)
Figure 56. China Medical Anti-infective Agent Sales Market Share by Type (2018-2029)
Figure 57. China Medical Anti-infective Agent Revenue Market Share by Type (2018-2029)
Figure 58. China Medical Anti-infective Agent Sales Market Share by Application (2018-2029)
Figure 59. China Medical Anti-infective Agent Revenue Market Share by Application (2018-2029)
Figure 60. Asia Medical Anti-infective Agent Sales Market Share by Type (2018-2029)
Figure 61. Asia Medical Anti-infective Agent Revenue Market Share by Type (2018-2029)
Figure 62. Asia Medical Anti-infective Agent Sales Market Share by Application (2018-2029)
Figure 63. Asia Medical Anti-infective Agent Revenue Market Share by Application (2018-2029)
Figure 64. Asia Medical Anti-infective Agent Revenue Share by Region (2018-2029)
Figure 65. Asia Medical Anti-infective Agent Sales Share by Region (2018-2029)
Figure 66. Japan Medical Anti-infective Agent Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Medical Anti-infective Agent Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Medical Anti-infective Agent Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Medical Anti-infective Agent Revenue (2018-2029) & (US$ Million)
Figure 70. India Medical Anti-infective Agent Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Medical Anti-infective Agent Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Medical Anti-infective Agent Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Medical Anti-infective Agent Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Medical Anti-infective Agent Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Medical Anti-infective Agent Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Medical Anti-infective Agent Sales Share by Country (2018-2029)
Figure 77. Brazil Medical Anti-infective Agent Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Medical Anti-infective Agent Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Medical Anti-infective Agent Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Medical Anti-infective Agent Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Medical Anti-infective Agent Revenue (2018-2029) & (US$ Million)
Figure 82. Medical Anti-infective Agent Value Chain
Figure 83. Medical Anti-infective Agent Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed